Verition Fund Management LLC Celldex Therapeutics, Inc. Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $1.79 Million - $3.26 Million	-87,230 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $922,291 - $1.31 Million	33,368 Added 61.95%	87,230 $2.97 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $1.92 Million - $3.03 Million	53,862 New	53,862 $2.08 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $2.76 Million - $4.71 Million	-133,064 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$16.19 - $29.91 $687,670 - $1.27 Million	-42,475 Reduced 24.2%	133,064 $2.74 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $118,645 - $180,066	7,915 Added 4.72%	175,539 $3.08 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $1.62 Million - $2.55 Million	167,624 New	167,624 $2.49 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.